These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Dengue fever: diagnosis and treatment. Wiwanitkit V Expert Rev Anti Infect Ther; 2010 Jul; 8(7):841-5. PubMed ID: 20586568 [TBL] [Abstract][Full Text] [Related]
47. [Effect of ribovirine (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboximide) on RNA-dependent RNA-polymerase induction and virus-specific polysome formation in cell cultures infected with influenza A virus]. Linitskaia GL; Iatsyna AA; Pushkarskaia NL; Galegov GA Vopr Med Khim; 1978; 24(5):699-702. PubMed ID: 568351 [No Abstract] [Full Text] [Related]
48. Testing antiviral compounds in a dengue mouse model. Schul W; Yip A; Shi PY Methods Mol Biol; 2013; 1030():269-81. PubMed ID: 23821275 [TBL] [Abstract][Full Text] [Related]
49. Oligonucleotide-Based Approaches to Inhibit Dengue Virus Replication. Panda K; Alagarasu K; Parashar D Molecules; 2021 Feb; 26(4):. PubMed ID: 33670247 [TBL] [Abstract][Full Text] [Related]
50. Stachyonic Acid: A Dengue Virus Inhibitor from Basilicum polystachyon. Tan YP; Houston SD; Modhiran N; Savchenko AI; Boyle GM; Young PR; Watterson D; Williams CM Chemistry; 2019 Apr; 25(22):5664-5667. PubMed ID: 30924209 [TBL] [Abstract][Full Text] [Related]
51. Synergistic experimental/computational studies on arylazoenamine derivatives that target the bovine viral diarrhea virus RNA-dependent RNA polymerase. Giliberti G; Ibba C; Marongiu E; Loddo R; Tonelli M; Boido V; Laurini E; Posocco P; Fermeglia M; Pricl S Bioorg Med Chem; 2010 Aug; 18(16):6055-68. PubMed ID: 20638852 [TBL] [Abstract][Full Text] [Related]
52. Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection. Alen MM; Kaptein SJ; De Burghgraeve T; Balzarini J; Neyts J; Schols D Virology; 2009 Apr; 387(1):67-75. PubMed ID: 19264337 [TBL] [Abstract][Full Text] [Related]
53. Prospects for the therapy and prevention of dengue virus infections. Damonte EB; Pujol CA; Coto CE Adv Virus Res; 2004; 63():239-85. PubMed ID: 15530563 [No Abstract] [Full Text] [Related]
54. An algal-derived DL-galactan hybrid is an efficient preventing agent for in vitro dengue virus infection. Talarico LB; Duarte ME; Zibetti RG; Noseda MD; Damonte EB Planta Med; 2007 Nov; 73(14):1464-8. PubMed ID: 17948168 [TBL] [Abstract][Full Text] [Related]
55. Unique heparan sulfate from shrimp heads exhibits a strong inhibitory effect on infections by dengue virus and Japanese encephalitis virus. Chen J; Yamada S; Hama Y; Shetty AK; Kobayashi T; Oda H; Seiki K; Kim E; Kimura T; Takahashi N; Hidari KI; Suzuki T; Suzuki Y; Sugahara K Biochem Biophys Res Commun; 2011 Aug; 412(1):136-42. PubMed ID: 21806963 [TBL] [Abstract][Full Text] [Related]
56. Biochemical characterization of the inhibition of the dengue virus RNA polymerase by beta-d-2'-ethynyl-7-deaza-adenosine triphosphate. Latour DR; Jekle A; Javanbakht H; Henningsen R; Gee P; Lee I; Tran P; Ren S; Kutach AK; Harris SF; Wang SM; Lok SJ; Shaw D; Li J; Heilek G; Klumpp K; Swinney DC; Deval J Antiviral Res; 2010 Aug; 87(2):213-22. PubMed ID: 20470829 [TBL] [Abstract][Full Text] [Related]
57. Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses. Villareal VA; Rodgers MA; Costello DA; Yang PL Antiviral Res; 2015 Dec; 124():110-21. PubMed ID: 26526588 [TBL] [Abstract][Full Text] [Related]
58. Important advances in the field of anti-dengue virus research. Julander JG; Perry ST; Shresta S Antivir Chem Chemother; 2011; 21(3):105-16. PubMed ID: 21233532 [TBL] [Abstract][Full Text] [Related]